Authors:
Gautschi, O
Tschopp, S
Olie, RA
Leech, SH
Simoes-Wust, AP
Ziegler, A
Baumann, B
Odermatt, B
Hall, J
Stahel, RA
Zangemeister-Wittke, U
Citation: O. Gautschi et al., Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins, J NAT CANC, 93(6), 2001, pp. 463
Citation: Ra. Olie et U. Zangemeister-wittke, Targeting tumor cell resistance to apoptosis induction with antisense oligonucleotides: progress and therapeutic potential, DRUG RESIST, 4(1), 2001, pp. 9-15
Authors:
Zangemeister-Wittke, U
Leech, SH
Olie, RA
Simoes-Wust, AP
Gautschi, O
Luedke, GH
Natt, F
Haner, R
Martin, P
Hall, J
Nalin, CM
Stahel, RA
Citation: U. Zangemeister-wittke et al., A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells, CLIN CANC R, 6(6), 2000, pp. 2547-2555
Authors:
Olie, RA
Simoes-Wust, AP
Baumann, B
Leech, SH
Fabbro, D
Stahel, RA
Zangemeister-Wittke, U
Citation: Ra. Olie et al., A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy, CANCER RES, 60(11), 2000, pp. 2805-2809